Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002
about
Oral insulinImpact of state mandatory insurance coverage on the use of diabetes preventive careThe Effect of the Vermont Diabetes Information System on Inpatient and Emergency Department Use: Results from a Randomized TrialOral insulin delivery: how far are we?Patient perceptions of quality of life with diabetes-related complications and treatmentsThe Vermont diabetes information system: a cluster randomized trial of a population based decision support systemUse of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesModulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsSystematic review and evaluation of web-accessible tools for management of diabetes and related cardiovascular risk factors by patients and healthcare providersQuality of care for patients with diabetes mellitus type 2 in 'model practices' in Slovenia - first resultsHealth disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statementEffect of an educational toolkit on quality of care: a pragmatic cluster randomized trialEffect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilization.The impact of tailored diabetes registry report cards on measures of disease control: a nested randomized trial.Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial.Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics.Exploring the feasibility of combining chronic disease patient registry data to monitor the status of diabetes care.DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients.Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.Physician support for diabetes patients and clinical outcomesIncidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to declineThe future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvementDiabetes Attitude Scale: validation in type-2 diabetes patients in multiple centers in China.From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management programIncreasing knowledge of cardiovascular risk factors among African Americans by use of community health workers: the ABCD community intervention pilot project.Process of care compliance is associated with fewer diabetes complicationsThe association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study.Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.Trends in sex differences in the receipt of quality of care indicators among adults with diabetes: United States 2002-2011.Rationale and design: telephone-delivered behavioral skills interventions for Blacks with Type 2 diabetes.Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.Diabetes control with reciprocal peer support versus nurse care management: a randomized trialCommunity-based participatory research and user-centered design in a diabetes medication information and decision toolFirst Things First: Difficulty with Current Medications Is Associated With Patient Willingness to Add New OnesThe Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial.Quality of type 2 diabetes management in the states of the Co-operation Council for the Arab States of the Gulf: a systematic review.Treatment intensification and risk factor control: toward more clinically relevant quality measures.Cardiovascular disease in type 2 diabetes: Attributable risk due to modifiable risk factors.Determinants of glycemic control in female diabetic patients: a study from Iran.Oral insulin - a review of current status.
P2860
Q21198761-DDC7A201-7007-49A8-A090-E967212A353AQ23920596-7A248E82-8FC7-4EB9-8F75-07DF0CAC2A13Q24629160-1E91C3AA-3691-423C-8722-BB18548DCD70Q24632900-FA9E991E-8337-41BD-A3A7-60ADBD5A67B4Q24644699-BDF30724-7A00-4971-A570-7DD28C977811Q24646428-23AC965B-418A-47CD-BAAD-ED03E9356FECQ24657307-68179993-446C-44C4-A83D-5A91F6D0C6B4Q26829098-6636B066-BE70-47F3-B4FA-3BF3E9FF2437Q26864145-535ADCB6-3964-4BFF-B5B1-23CB59A89601Q28069209-55B23539-7F72-4DCB-BBA4-7FE2C6A3A6C4Q28388174-439CFB8B-1472-4CE0-AF00-9190B578038BQ28539476-A6EA47AC-A3FE-419D-9385-E570806D2E24Q30484030-F40710BB-506F-46E2-A4C0-E80712A70FF4Q30498381-C55CB77A-885F-494C-B941-6B075B2B16D1Q31070536-2B62622B-4CBD-4F62-92E7-59EB2ADA5C3FQ33359337-EA630F85-0C4E-4824-B49D-4E3BCF94FB62Q33369645-0269D931-593C-47B4-92D6-E30C45BC86A9Q33441019-BCD4EC68-12BA-4406-A356-3B4041E87CAAQ33464541-D3B3941F-DD7E-40EC-9BE2-52AC95F50880Q33507440-8747921B-C6BB-4649-8A24-B229DB1E5BC2Q33556901-F742E3DA-C5FE-402B-9F5A-17107A98FF14Q33569607-D6B6B35A-E009-487A-9D46-3297CEF8EE24Q33573266-9E76CD93-C0EE-4D16-B2BB-D9EF97943B0DQ33577432-9B5400DF-E36A-4D97-846C-9693539E44BEQ33595985-1FA5154C-F480-434A-81C3-097C8F9262F8Q33711157-AD8EAB2F-05E7-4749-BD34-D2076ED931F3Q33723318-0B48F05A-B650-4A88-841A-081273C944C7Q33770056-0E8DC36D-95CD-434C-99BF-7136C0401CB7Q33771591-CA805F82-A450-42E0-8FA9-6CE565DBC518Q33793227-E15AD432-2E20-475E-8BDA-CC07E80DB4D6Q33873025-85CC7F6E-1C4C-4A7D-9E48-E726FDA8B0C0Q33981420-7749C186-448D-402B-8738-7146BF066295Q33981486-CB4DF289-EE57-4C43-88C3-1CA0FEC95307Q33985188-AC4B6E65-2279-4BE6-B302-8E7C457E8737Q33986499-90E6B4E9-40FB-422F-8F16-7B15B278BB9DQ33988339-58744B1A-DB4C-49A0-B2DB-43DD1BCE084DQ33988413-48CF36A3-A287-42FE-AF58-0C568C9893C9Q34062652-72BF6EEF-EE92-4CE1-9106-3343AB647B33Q34098042-B9A65A62-75C0-49BF-8D49-1682D5257B63Q34098447-E39E04F5-A5E8-4F24-88E9-778CA74D6285
P2860
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Improvements in diabetes proce ...... omes: United States, 1988-2002
@ast
Improvements in diabetes proce ...... omes: United States, 1988-2002
@en
Improvements in diabetes proce ...... omes: United States, 1988-2002
@nl
type
label
Improvements in diabetes proce ...... omes: United States, 1988-2002
@ast
Improvements in diabetes proce ...... omes: United States, 1988-2002
@en
Improvements in diabetes proce ...... omes: United States, 1988-2002
@nl
prefLabel
Improvements in diabetes proce ...... omes: United States, 1988-2002
@ast
Improvements in diabetes proce ...... omes: United States, 1988-2002
@en
Improvements in diabetes proce ...... omes: United States, 1988-2002
@nl
P2093
P3181
P1476
Improvements in diabetes proce ...... omes: United States, 1988-2002
@en
P2093
Betsy Cadwell
Frank Vinicor
Jinan B Saaddine
K M Venkat Narayan
Michael M Engelgau
P304
P3181
P356
10.7326/0003-4819-144-7-200604040-00005
P407
P577
2006-04-04T00:00:00Z